Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Sarcoidosis can cause severe high calcium levels, hair loss, and kidney failure.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.